Mankind Pharma Limited has informed the Exchange about General Updates
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has received a favorable order from the Additional Commissioner, CGST (Appeals), Meerut, dropping a penalty of ₹1,02,05,688 (approximately ₹10.2 crore) that had been imposed on the company. The penalty was originally levied by the Assistant Commissioner under Section 74 of the CGST Act, 2017 for the financial years 2017-18 to 2020-21. The company had filed an appeal against this order in December 2024, and the appellate authority has now ruled in the company's favor. The order was received on February 25, 2026.
This is a positive outcome for shareholders — the company successfully appealed and got a ₹10.2 crore GST penalty set aside, saving that amount. It removes an overhang of potential financial liability and reflects well on the company's ability to defend itself in tax matters.